drugset / Trial / NCT07271147
Effects of taVNS Combined With Dexmedetomidine on POVN
RandomizedParallel-groupDouble-blindPrevention
Summary
To explore the effects and possible mechanisms of dexmedetomidine combined with taVNS on the incidence of postoperative nausea and vomiting in female patients undergoing laparoscopic surgery
Timeline
- Start
- 2025-11-07
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | Intravenous |
Indications
No indication recorded.